Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Goro Kasuya"'
Autor:
Yu‐Mei Kang, Hitoshi Ishikawa, Taku Inaniwa, Yuma Iwai, Naruhiro Matsufuji, Goro Kasuya, Noriyuki Okonogi, Yu‐Ming Liu, Yee Chao, Masaru Wakatsuki, Hirohiko Tsujii, Hiroshi Tsuji
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1540-1551 (2023)
Abstract Background To evaluate the clinical relative biological effectiveness (RBE) of carbon‐ion radiotherapy (C‐ion RT) for prostate cancer. Methods The records of 262 patients with low‐risk prostate cancer (median age, 65 [47–80] years) t
Externí odkaz:
https://doaj.org/article/657a12567feb4079b501c0bdc886484e
Autor:
Shigeo Yasuda, MD, PhD, Hirotoshi Kato, MD, PhD, Hiroshi Imada, MD, PhD, Yuka Isozaki, MD, PhD, Goro Kasuya, MD, PhD, Hirokazu Makishima, MD, PhD, Hiroshi Tsuji, MD, PhD, Daniel K. Ebner, BS, Shigeru Yamada, MD, PhD, Tadashi Kamada, MD, PhD, Hirohiko Tsujii, MD, PhD, Naoya Kato, MD, PhD, Masaru Miyazaki, MD, PhD, Shigeki Arii, Masaaki Ebara, Junji Furuse, Kiyoshi Ohara, Takuji Okusaka, Takehito Otsubo, Masayuki Otsuka, Fumihoko Kanai, Fukuo Kondo, Akiko Saito, Yoshiaki Shimizu, Kenichi Takayasu, Ikuo Udagawa, Hiroshi Yamamoto, Junji Yamamoto, Masakazu Yamamoto, Osamu Yokosuka, Hiroyuki Yoshidome
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 2, Pp 196-203 (2020)
Purpose: Carbon ion beams have several physical and biological advantages compared with conventional radiation for cancer therapy. The objective of this study is to evaluate the safety and effectiveness of 2-fraction carbon ion radiation therapy (CIR
Externí odkaz:
https://doaj.org/article/ab17cbd4745440de837ee7b8a05c953f
Autor:
Takashi Ono, Naoyoshi Yamamoto, Akihiro Nomoto, Mio Nakajima, Yuma Iwai, Yuka Isozaki, Goro Kasuya, Hitoshi Ishikawa, Kenji Nemoto, Hiroshi Tsuji
Publikováno v:
Cancers, Vol 13, Iss 13, p 3229 (2021)
There are no studies on the risk factors of radiation pneumonitis (RP) after carbon-ion radiotherapy at a dose of 50 Gy (relative biological effectiveness (RBE)) in a single fraction. The objective of this study was to identify factors associated wit
Externí odkaz:
https://doaj.org/article/8841d8e680a9468a95eb9f6fcd977467
Autor:
Takashi Ono, Naoyoshi Yamamoto, Akihiro Nomoto, Mio Nakajima, Yuka Isozaki, Goro Kasuya, Hitoshi Ishikawa, Kenji Nemoto, Hiroshi Tsuji
Publikováno v:
Cancers, Vol 13, Iss 1, p 112 (2020)
Background: The purpose of the present study was to evaluate the efficacy and safety of single-fraction carbon-ion radiotherapy (CIRT) in patients with non-small cell lung cancer. Methods: Patients with histologically confirmed non-small cell lung ca
Externí odkaz:
https://doaj.org/article/72e199c1959a4772aa0d36d5b9be2f63
Autor:
Yu‐Mei Kang, Hitoshi Ishikawa, Taku Inaniwa, Yuma Iwai, Naruhiro Matsufuji, Goro Kasuya, Noriyuki Okonogi, Yu‐Ming Liu, Yee Chao, Masaru Wakatsuki, Hirohiko Tsujii, Hiroshi Tsuji
Publikováno v:
Cancer Medicine. 12:1540-1551
To evaluate the clinical relative biological effectiveness (RBE) of carbon-ion radiotherapy (C-ion RT) for prostate cancer.The records of 262 patients with low-risk prostate cancer (median age, 65 [47-80] years) treated with C-ion RT at QST Hospital,
Autor:
Ono Takashi, Yuka Isozaki, Hiraku Sato, Yuma Iwai, Akihiro Nomoto, Hitoshi Ishikawa, Kenji Nemoto, Naoyoshi Yamamoto, Tomohiko Ichikawa, Hiroshi Tsuji, Goro Kasuya, Mio Nakajima
Publikováno v:
Cancer Science
There are no clinical reports of long‐term follow‐up after carbon‐ion radiotherapy (CIRT) using a dose of 51.6 Gy (relative biological effectiveness [RBE]) in 12 fractions for localized prostate cancer, or of a comparison of clinical outcomes b
Autor:
Sato, Hiraku, Kasuya, Goro, Ishikawa, Hitoshi, Nomoto, Akihiro, Ono, Takashi, Nakajima, Mio, Isozaki, Yuka, Yamamoto, Naoyoshi, Iwai, Yuma, Nemoto, Kenji, Ichikawa, Tomohiko, Tsuji, Hiroshi, Hiraku, Sato, Goro, Kasuya, Hitoshi, Ishikawa, Akihiro, Nomoto, Takashi, Ono, Mio, Nakajima, Yuka, Isozaki, Naoyoshi, Yamamoto, Yuma, Iwai, Kenji, Nemoto, Hiroshi, Tsuji
Publikováno v:
Cancer science. 112(9):3598-3606
There are no clinical reports of long-term follow-up after carbon-ion radiotherapy (CIRT) using a dose of 51.6Gy (relative biological effectiveness [RBE]) in 12 fractions for localized prostate cancer, or of a comparison of clinical outcomes between
Autor:
Yamazaki, Kana, Nishii, Ryuichi, Maeda, Takamasa, Makishima, Hirokazu, Kasuya, Goro, Chang, Tachen, Tamura, Kentaro, Wakatsuki, Masaru, Tsuji, Hiroshi, Murakami, Koji, Higashi, Tatsuya, Kana, Yamazaki, Ryuichi, Nishii, Takamasa, Maeda, Hirokazu, Makishima, Goro, Kasuya, Kentaro, Tamura, Masaru, Wakatsuki, Hiroshi, Tsuji, Koji, Murakami, Tatsuya, Higashi
Publikováno v:
Annals of nuclear medicine. 34:864-872
The aim of this study was to assess the diagnostic ability of N-isopropyl-p-[I-123] iodoamphetamine (IMP) SPECT semi-quantitative evaluation based on the standardized uptake value (SUV) in patients with choroidal melanoma. The secondary aim was to in
Autor:
Hirokazu Makishima, Takamasa Maeda, Kana Yamazaki, Kentaro Tamura, Koji Murakami, Ryuichi Nishii, Tachen Chang, Tatsuya Higashi, Hiroshi Tsuji, Masaru Wakatsuki, Goro Kasuya
Publikováno v:
Annals of Nuclear Medicine. 34:864-872
The aim of this study was to assess the diagnostic ability of N-isopropyl-p-[I-123] iodoamphetamine (IMP) SPECT semi-quantitative evaluation based on the standardized uptake value (SUV) in patients with choroidal melanoma. The secondary aim was to in
Autor:
Tatsuya Higashi, Yoko Ikoma, Goro Kasuya, Takayuki Obata, Hiroshi Tsuji, Tokuhiko Omatsu, Hirokazu Makishima, Riwa Kishimoto, Yasuhiko Tachibana
Publikováno v:
Magnetic Resonance Imaging. 66:185-192
Purpose Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) measures changes in the concentration of an administered contrast agent to quantitatively evaluate blood circulation in a tumor or normal tissues. This method uses a pharmacokinet